Form 4: Arcutis Biotherapeutics Director Sells Shares
Insider Transaction (Form 4)
Howard G. Welgus, a Director of Arcutis Biotherapeutics, Inc., sold 4,730 shares of common stock on July 15, 2026 for $26.91 per share.
Summary
- Option exercise/conversion: acquired 822 Common Stock at $6.52 ($5,361) on July 15, 2026; holds 38,565 after (Direct).
- Option exercise/conversion: acquired 1,019 Common Stock at $7.51 ($7,653) on July 15, 2026; holds 39,584 after (Direct).
- Option exercise/conversion: acquired 2,255 Common Stock at $8.63 ($19,461) on July 15, 2026; holds 41,839 after (Direct).
- Open-market sale: disposed of 4,730 Common Stock at $26.91 ($127,284) on July 15, 2026; holds 37,109 after (Direct).
- Option exercise/conversion: disposed of 822 Stock Option (right to buy) on July 15, 2026; holds 8,218 after (Direct).
- Option exercise/conversion: disposed of 1,019 Stock Option (right to buy) on July 15, 2026; holds 10,182 after (Direct).
- Option exercise/conversion: disposed of 2,255 Stock Option (right to buy) on July 15, 2026; holds 22,542 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $127,284 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Howard G. Welgus — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Option exercise/conversion | Common Stock | 822 | $7 | $5.4K | 38,565 |
| 2026-07-15 | Option exercise/conversion | Common Stock | 1,019 | $8 | $7.7K | 39,584 |
| 2026-07-15 | Option exercise/conversion | Common Stock | 2,255 | $9 | $19.5K | 41,839 |
| 2026-07-15 | Open-market sale | Common Stock | 4,730 | $27 | $127.3K | 37,109 |
| 2026-07-15 | Option exercise/conversion | Stock Option (right to buy) | 822 | — | — | 8,218 |
| 2026-07-15 | Option exercise/conversion | Stock Option (right to buy) | 1,019 | — | — | 10,182 |
| 2026-07-15 | Option exercise/conversion | Stock Option (right to buy) | 2,255 | — | — | 22,542 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Option exercise/conversion (822 shares) |
| 2026-07-15 | Option exercise/conversion (1,019 shares) |
| 2026-07-15 | Option exercise/conversion (2,255 shares) |
| 2026-07-15 | Open-market sale (4,730 shares) |
| 2026-07-15 | Option exercise/conversion (822 shares) |
| 2026-07-15 | Option exercise/conversion (1,019 shares) |
| 2026-07-15 | Option exercise/conversion (2,255 shares) |
Keywords
insider transaction, Form 4, ARQT, Arcutis Biotherapeutics, Inc., bearish, Howard G. Welgus
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.